Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,610 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Discovery of RNA Aptamers that Selectively Bind Glioblastoma Stem Cells.
Affinito A, Quintavalle C, Esposito CL, Roscigno G, Vilardo C, Nuzzo S, Ricci-Vitiani L, De Luca G, Pallini R, Kichkailo AS, Lapin IN, de Franciscis V, Condorelli G. Affinito A, et al. Among authors: de franciscis v, de luca g. Mol Ther Nucleic Acids. 2019 Dec 6;18:99-109. doi: 10.1016/j.omtn.2019.08.015. Epub 2019 Aug 22. Mol Ther Nucleic Acids. 2019. PMID: 31541799 Free PMC article.
Cancer Stem Cell-Based Models of Colorectal Cancer Reveal Molecular Determinants of Therapy Resistance.
De Angelis ML, Zeuner A, Policicchio E, Russo G, Bruselles A, Signore M, Vitale S, De Luca G, Pilozzi E, Boe A, Stassi G, Ricci-Vitiani L, Amoreo CA, Pagliuca A, Francescangeli F, Tartaglia M, De Maria R, Baiocchi M. De Angelis ML, et al. Among authors: de maria r, de luca g. Stem Cells Transl Med. 2016 Apr;5(4):511-23. doi: 10.5966/sctm.2015-0214. Epub 2016 Mar 8. Stem Cells Transl Med. 2016. PMID: 26956206 Free PMC article.
Mir-370-3p Impairs Glioblastoma Stem-Like Cell Malignancy Regulating a Complex Interplay between HMGA2/HIF1A and the Oncogenic Long Non-Coding RNA (lncRNA) NEAT1.
Lulli V, Buccarelli M, Ilari R, Castellani G, De Dominicis C, Di Giamberardino A, D Alessandris QG, Giannetti S, Martini M, Stumpo V, Boe A, De Luca G, Biffoni M, Marziali G, Pallini R, Ricci-Vitiani L. Lulli V, et al. Among authors: de luca g, de dominicis c. Int J Mol Sci. 2020 May 20;21(10):3610. doi: 10.3390/ijms21103610. Int J Mol Sci. 2020. PMID: 32443824 Free PMC article.
Elesclomol-induced increase of mitochondrial reactive oxygen species impairs glioblastoma stem-like cell survival and tumor growth.
Buccarelli M, D'Alessandris QG, Matarrese P, Mollinari C, Signore M, Cappannini A, Martini M, D'Aliberti P, De Luca G, Pedini F, Boe A, Biffoni M, Pallini R, Ricci-Vitiani L. Buccarelli M, et al. Among authors: de luca g. J Exp Clin Cancer Res. 2021 Jul 12;40(1):228. doi: 10.1186/s13046-021-02031-4. J Exp Clin Cancer Res. 2021. PMID: 34253243 Free PMC article.
The kinase inhibitor SI113 induces autophagy and synergizes with quinacrine in hindering the growth of human glioblastoma multiforme cells.
Matteoni S, Abbruzzese C, Matarrese P, De Luca G, Mileo AM, Miccadei S, Schenone S, Musumeci F, Haas TL, Sette G, Carapella CM, Amato R, Perrotti N, Signore M, Paggi MG. Matteoni S, et al. Among authors: de luca g. J Exp Clin Cancer Res. 2019 May 17;38(1):202. doi: 10.1186/s13046-019-1212-1. J Exp Clin Cancer Res. 2019. PMID: 31101126 Free PMC article.
Joint action of miR-126 and MAPK/PI3K inhibitors against metastatic melanoma.
Pedini F, De Luca G, Felicetti F, Puglisi R, Boe A, Arasi MB, Fratini F, Mattia G, Spada M, Caporali S, Biffoni M, Giuliani A, Carè A, Felli N. Pedini F, et al. Among authors: de luca g. Mol Oncol. 2019 Sep;13(9):1836-1854. doi: 10.1002/1878-0261.12506. Epub 2019 Aug 6. Mol Oncol. 2019. PMID: 31115969 Free PMC article.
MiR126-targeted-nanoparticles combined with PI3K/AKT inhibitor as a new strategy to overcome melanoma resistance.
Arasi MB, De Luca G, Chronopoulou L, Pedini F, Petrucci E, Flego M, Stringaro A, Colone M, Pasquini L, Spada M, Lulli V, Perrotta MC, Calin GA, Palocci C, Biffoni M, Felicetti F, Felli N. Arasi MB, et al. Among authors: de luca g. Mol Ther. 2024 Jan 3;32(1):152-167. doi: 10.1016/j.ymthe.2023.11.021. Epub 2023 Nov 21. Mol Ther. 2024. PMID: 37990493 Free article.
ADAR1 is a new target of METTL3 and plays a pro-oncogenic role in glioblastoma by an editing-independent mechanism.
Tassinari V, Cesarini V, Tomaselli S, Ianniello Z, Silvestris DA, Ginistrelli LC, Martini M, De Angelis B, De Luca G, Vitiani LR, Fatica A, Locatelli F, Gallo A. Tassinari V, et al. Among authors: de angelis b, de luca g. Genome Biol. 2021 Jan 28;22(1):51. doi: 10.1186/s13059-021-02271-9. Genome Biol. 2021. PMID: 33509238 Free PMC article.
1,610 results